MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 74 filers reported holding MARKER THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,731 | -45.4% | 10,273 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | -50.0% | 10,273 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $10,000 | -41.2% | 10,273 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $17,000 | -41.4% | 10,273 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $29,000 | +26.1% | 10,273 | 0.0% | 0.01% | +20.0% |
| Q1 2021 | $23,000 | +53.3% | 10,273 | 0.0% | 0.01% | +66.7% |
| Q4 2020 | $15,000 | 0.0% | 10,273 | 0.0% | 0.00% | -25.0% |
| Q3 2020 | $15,000 | -28.6% | 10,273 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $21,000 | +5.0% | 10,273 | 0.0% | 0.01% | -14.3% |
| Q1 2020 | $20,000 | -33.3% | 10,273 | 0.0% | 0.01% | -22.2% |
| Q4 2019 | $30,000 | -42.3% | 10,273 | 0.0% | 0.01% | -43.8% |
| Q3 2019 | $52,000 | -35.8% | 10,273 | 0.0% | 0.02% | -36.0% |
| Q2 2019 | $81,000 | +19.1% | 10,273 | 0.0% | 0.02% | +13.6% |
| Q1 2019 | $68,000 | +19.3% | 10,273 | 0.0% | 0.02% | 0.0% |
| Q4 2018 | $57,000 | – | 10,273 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 2,000,000 | $4,140,000 | 1.58% |
| NEA Management Company, LLC | 5,000,000 | $10,350,000 | 0.42% |
| Vigilare Wealth Management | 103,450 | $214,000 | 0.22% |
| Riggs Asset Managment Co. Inc. | 37,500 | $77,000 | 0.03% |
| WEDBUSH SECURITIES INC | 110,174 | $228,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 18,450 | $38,000 | 0.02% |
| MERIDIAN MANAGEMENT CO | 17,812 | $37,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 223,216 | $462,000 | 0.01% |
| NEVILLE RODIE & SHAW INC | 30,101 | $62,000 | 0.01% |
| Ascent Wealth Partners, LLC | 10,273 | $21,000 | 0.01% |